Frazier Life Sciences XI, L.P.
CIK 1911592 · last filed 2026-08-06
Frazier Life Sciences XI, L.P. is a corporate insider who has filed 1 SEC Form 4 insider transactions across 1 company since 2026. The most recent filing, for ATTO, was dated Aug 6, 2026. Across all open-market trades the lifetime net is +$30.0M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $46.6M across reported positions. The firm reports its address in Palo Alto, CA. 2 SEC filings were submitted jointly with Attovia Therapeutics, Inc.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$46.62M
1
1
$30.00M
Filer Profile
BUILDING 4, SUITE 200B
PALO ALTO, CA 94304
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ATTO | 10%+ Owner | 1,824,541 | $25.55 | $46.62M | $30.00M | 1 | 2026-08-06 |
Recent Filings
1 filingNotice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.